United States, Rhode Island — Warwick, Rhode Island

United States, Rhode Island is a clinical research site located in Warwick, Rhode Island, United States 02888.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

United States, Rhode Island has participated in 1 clinical trials.

Therapeutic areas: Mesopic Vision, Night Vision Loss.

Sponsors: Ocuphire Pharma, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States, Rhode Island?

United States, Rhode Island has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States, Rhode Island conducted?

United States, Rhode Island has 1 clinical trials on record. Their work covers Mesopic Vision, Night Vision Loss.

Is United States, Rhode Island accredited by Crixeo Health?

United States, Rhode Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States, Rhode Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.